Common Stock |
9 Months Ended |
|---|---|
Apr. 30, 2025 | |
| Common Stock [Abstract] | |
| COMMON STOCK | NOTE 8 – COMMON STOCK
On January 15, 2025, the Company entered into certain securities purchase agreement with certain non-affiliated institutional investors pursuant to which the Company agreed to sell 3,820,000 of its ordinary shares in a registered direct offering, for gross proceeds of approximately $4.7 million. The purchase price for each Ordinary Share is $1.25.
On February 4, 2025, the Company entered into certain securities purchase agreement with certain non-affiliated institutional investor pursuant to which the Company agreed to sell (1) 1,580,000 ordinary shares, par value $0.001 per share, and (2) certain pre-funded warrants to purchase up to 887,553 Ordinary Shares in a registered direct offering, and (3) in a concurrent private placement, restricted warrants to purchase an aggregate of up to 2,467,553 Ordinary Shares, for aggregate gross proceeds of approximately $2.5 million. The purchase price for each Ordinary Share is $1
As of April 30, 2025, the Company had 100,000,000,000 authorized ordinary shares, and 17,317,452 ordinary shares were issued and outstanding, respectively. |